Published in J Neurol on December 01, 2001
Neurologic uses of botulinum neurotoxin type A. Neuropsychiatr Dis Treat (2007) 1.02
Botulinum toxin type A in the treatment of patients with cervical dystonia. Biologics (2009) 0.98
An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open (2013) 0.90
Botulinum toxin therapy for cervical dystonia: the science of dosing. Tremor Other Hyperkinet Mov (N Y) (2014) 0.86
A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis. BMJ Open (2011) 0.86
Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study. Mov Disord (2014) 0.82
British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin. Pract Neurol (2016) 0.82
Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment. Toxins (Basel) (2015) 0.79
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. J Neural Transm (Vienna) (2012) 0.79
Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A. Patient Prefer Adherence (2015) 0.77
Botulinum toxin type A with or without needle electromyographic guidance in patients with cervical dystonia. Springerplus (2016) 0.75
Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Front Neurol (2017) 0.75
Anatomy and cervical dystonia : "Dysfunction follows form". J Neural Transm (Vienna) (2016) 0.75
The clinical phenomenology and associations of trick maneuvers in cervical dystonia. J Neural Transm (Vienna) (2015) 0.75
Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol (1977) 20.29
Procedure for identifying nonsense mutations. J Bacteriol (1968) 8.16
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Ultrastructural localization of intracellular antigens by the use of protein A-gold complex. J Histochem Cytochem (1978) 7.15
Immunocytochemical localization of galactosyltransferase in HeLa cells: codistribution with thiamine pyrophosphatase in trans-Golgi cisternae. J Cell Biol (1982) 6.67
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A (1974) 5.73
The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med (1976) 5.09
Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A (1981) 4.85
Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J Histochem Cytochem (1981) 4.62
Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (1982) 4.22
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Cluster of genes controlling proline degradation in Salmonella typhimurium. J Bacteriol (1978) 4.04
PCR-induced (ligase-free) subcloning: a rapid reliable method to subclone polymerase chain reaction (PCR) products. Nucleic Acids Res (1990) 3.93
Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun (1971) 3.74
Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci U S A (1971) 3.65
Demonstration of an extensive trans-tubular network continuous with the Golgi apparatus stack that may function in glycosylation. Cell (1985) 3.54
Hybrid DNA artifact from PCR of closely related target sequences. Nucleic Acids Res (1989) 3.54
dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science (1998) 3.48
Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun (1973) 3.41
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother (1992) 3.19
The 17-gene ethanolamine (eut) operon of Salmonella typhimurium encodes five homologues of carboxysome shell proteins. J Bacteriol (1999) 3.17
Insulin receptors are widely distributed in the central nervous system of the rat. Nature (1978) 3.07
Su(z)12, a novel Drosophila Polycomb group gene that is conserved in vertebrates and plants. Development (2001) 3.06
Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J Biol Chem (1988) 3.05
Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem (1974) 3.04
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem (1976) 3.01
Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science (1975) 2.97
Does oxidative damage to DNA increase with age? Proc Natl Acad Sci U S A (2001) 2.91
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Regulation of the major proline permease gene of Salmonella typhimurium. J Bacteriol (1978) 2.87
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J Biol Chem (1973) 2.80
Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation. J Biol Chem (1972) 2.78
Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation (1992) 2.77
The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem (1998) 2.72
Polycomb group proteins and heritable silencing of Drosophila Hox genes. Development (2001) 2.67
Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet (1966) 2.65
Characteristics of the human lymphocyte insulin receptor. J Biol Chem (1973) 2.61
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl (1987) 2.61
Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem (1997) 2.57
Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57
Plasma insulin and growth hormone levels in obesity and diabetes. Ann N Y Acad Sci (1965) 2.56
Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J (1997) 2.44
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 2.36
Degradation of misfolded endoplasmic reticulum glycoproteins in Saccharomyces cerevisiae is determined by a specific oligosaccharide structure. J Cell Biol (1998) 2.33
Transmission of glioblastoma multiforme through liver transplantation. Lancet (1998) 2.33
dMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties. EMBO J (2000) 2.31
Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem (1998) 2.28
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Insulin receptors in human circulating cells and fibroblasts. Proc Natl Acad Sci U S A (1972) 2.24
The DNA-binding polycomb group protein pleiohomeotic mediates silencing of a Drosophila homeotic gene. Development (1999) 2.24
Peptide hormone binding to receptors: a review of direct studies in vitro. Metabolism (1973) 2.23
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
Octreotide therapy for tumor-induced osteomalacia. N Engl J Med (2001) 2.19
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation (1997) 2.18
Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. J Clin Invest (1976) 2.12
ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci U S A (1970) 2.09
Anomalies in polysome profiles caused by contamination of the gradients with Cu 2+ or Zn 2+ . Biochim Biophys Acta (1971) 2.08
Methods for assessing immunologic and biologic properties of iodinated peptide hormones. Methods Enzymol (1975) 2.01
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab (1997) 1.99
Binding of hormone to tissue: the first step in polypeptide hormone action. Proc Natl Acad Sci U S A (1966) 1.96
Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun (1997) 1.96
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol (2000) 1.96
Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.95
The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol Med (1996) 1.94
Consulting the public about health service priorities. BMJ (1995) 1.93
Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. J Clin Invest (1975) 1.92
Control of blood glucose and diabetic vascular disease. N Engl J Med (1977) 1.92
The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev (1982) 1.92
Identification and mapping of a second proline permease Salmonella typhimurium. J Bacteriol (1980) 1.91
Purification of the putA gene product. A bifunctional membrane-bound protein from Salmonella typhimurium responsible for the two-step oxidation of proline to glutamate. J Biol Chem (1981) 1.91
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Transcriptional silencing of homeotic genes in Drosophila. Bioessays (1995) 1.88
Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun (1975) 1.87
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology (2005) 1.86
Glucose intolerance in cystic fibrosis. N Engl J Med (1969) 1.85
Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J Neurosci (1997) 1.85
Determining priorities for purchasers. The public response to rationing within the NHS. J Manag Med (1997) 1.84
Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson's disease. Mov Disord (2001) 1.83
Efficacy of conventional pituitary irradiation in acromegaly. N Engl J Med (1970) 1.82
Molecular cloning of higher plant homologues of the high-affinity nitrate transporters of Chlamydomonas reinhardtii and Aspergillus nidulans. Gene (1996) 1.80
Quantitative immunocytochemical localization of pancreatic secretory proteins in subcellular compartments of the rat acinar cell. J Histochem Cytochem (1980) 1.80
Insulin receptor deficiency in genetic and acquired obesity. J Clin Invest (1975) 1.79
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology (2005) 1.77
Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol (2001) 1.77
Coloidal gold, ferritin and peroxidase as markers for electron microscopic double labeling lectin techniques. J Histochem Cytochem (1978) 1.77
Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) (1983) 1.75
Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest (1976) 1.74
Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol (2000) 1.74
Regulation of the genes for proline utilization in Salmonella typhimurium: autogenous repression by the putA gene product. J Mol Biol (1981) 1.74
Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease): three cases without evidence of "flexion myelopathy". Acta Neurol Scand (2001) 1.74
A new look at the microtubule binding patterns of dimeric kinesins. J Mol Biol (2000) 1.73